LONG-TERM EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY BASELINE BODY MASS INDEX

被引：2
|
作者：
Chupp, Geoffrey L.
Lugogo, Njira L.
Wechsler, Michael E.
Lawson, Kaitlyn
Lindsley, Andrew
Spahn, Joe D.
Ambrose, Christopher
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.075
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：9A / 14A
页数：6
相关论文
共 50 条
  • [11] Effect of Tezepelumab on Exacerbations in Patients with Severe, Uncontrolled Asthma, According to Baseline Body Mass Index: Results from the Phase 2b PATHWAY Study
    Ambrose, Chris
    Colice, Gene
    Salapa, Kinga
    Parnes, Jane
    Corren, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB25 - AB25
  • [12] TEZEPELUMAB EFFICACY ACCORDING TO BRONCHODILATOR REVERSIBILITY IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN NAVIGATOR
    Menzies-Gow, A.
    Bourdin, A.
    Korn, S.
    Cook, B.
    Ambrose, C.
    Ponnarambil, S.
    Hunter, G.
    Molfino, N.
    Colice, G.
    Llanos-Ackert, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S37 - S37
  • [13] Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
    Menzies-Gow, Andrew
    Wechsler, Michael E.
    Brightling, Christopher E.
    Korn, Stephanie
    Corren, Jonathan
    Israel, Elliot
    Chupp, Geoffrey
    Bednarczyk, Artur
    Ponnarambil, Sandhia
    Caveney, Scott
    Almqvist, Gun
    Golabek, Monika
    Simonsson, Linda
    Lawson, Kaitlyn
    Bowen, Karin
    Colice, Gene
    LANCET RESPIRATORY MEDICINE, 2023, 11 (05): : 425 - 438
  • [14] TEZEPELUMAB EFFECTS ON INFLAMMATORY BIOMARKERS IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY BASELINE BIOMARKER LEVEL
    Lugogo, N.
    Chupp, G.
    Corren, J.
    Israel, E.
    Molfino, N.
    Martin, N.
    Spahn, J.
    Ambrose, C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S53 - S54
  • [15] Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR 
    Laidlaw, Tanya M.
    Menzies-Gow, Andrew
    Caveney, Scott
    Han, Joseph K.
    Martin, Nicole
    Israel, Elliot
    Lee, Jason K.
    Llanos, Jean-Pierre
    Martin, Neil
    Megally, Ayman
    Parikh, Bhavini
    Vong, Sylvia
    Welte, Tobias
    Corren, Jonathan
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 915 - 932
  • [16] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
    Welte, T.
    Menzies-Gow, A.
    Israel, E.
    Corren, J.
    Hunter, G.
    Cook, W.
    Colice, G.
    Lanos-Ackert, P. J.
    PNEUMOLOGIE, 2022, 76 : S12 - S12
  • [17] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
    Menzies-Gow, Andrew
    Corren, Jonathan
    Israel, Elliot
    Welte, Tobias
    Ambrose, Christopher S.
    Cook, Bill
    Hunter, Gillian
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [18] LONG-TERM EFFICACY OF OMALIZUMAB IN PATIENTS WITH SEVERE ASTHMA
    Saji, J.
    Yamamoto, T.
    Arai, M.
    Mineshita, M.
    Miyazawa, T.
    RESPIROLOGY, 2014, 19 : 7 - 7
  • [19] Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
    Domingo, Christian
    Rabe, Klaus F.
    Price, David
    Brusselle, Guy
    Wechsler, Michael E.
    Xia, Changming
    Pandit-Abid, Nami
    Gall, Rebecca
    Rowe, Paul J.
    Deniz, Yamo
    Jacob-Nara, Juby A.
    Radwan, Amr
    ERJ OPEN RESEARCH, 2023, 9 (06)
  • [20] Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma
    Odajima, Hiroshi
    Ebisawa, Motohiro
    Nagakura, Toshikazu
    Fujisawa, Takao
    Akasawa, Akira
    Ito, Komei
    Doi, Satoru
    Yamaguchi, Koichi
    Katsunuma, Toshio
    Kurihara, Kazuyuki
    Teramoto, Takahide
    Sugai, Kazuko
    Nambu, Mitsuhiko
    Hoshioka, Akira
    Yoshihara, Shigemi
    Sato, Norio
    Seko, Noriko
    Nishima, Sankei
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 106 - 115
12345